InsiderClue
Stocks · Health care · Pharmaceutical Preparations

iBio, Inc.

IBIO Clue Score37
United States Fiscal year ends June CIK 0001420720
$0.87 -5.33% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.87 −6.34% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.4Operating income−14.3Net income−14.5Fiscal year 2018Revenue0.4 +12.7%Operating income−14.2Net income−16.1Fiscal year 2019Revenue2.0 +354.5%Operating income−15.8Net income−17.6Fiscal year 2020Revenue1.6 −18.8%Operating income−14.0Net income−16.4Fiscal year 2021Revenue2.4 +44.7%Operating income−31.1Net income−23.2EPS, diluted−3.00Fiscal year 2022Revenue1.9 −20.5%Operating income−29.7Net income−50.3EPS, diluted−5.78Fiscal year 2023Revenue0.0 −100.0%Operating income−29.3Net income−65.0EPS, diluted−106.19Fiscal year 2024Revenue0.2Operating income−16.6Net income−24.9EPS, diluted−6.50Fiscal year 2025Revenue0.4 +77.8%Operating income−18.6Net income−18.4EPS, diluted−1.75Fiscal year 2026Revenue0.1 −75.0%Operating income−35.1Net income−33.0EPS, diluted−0.32
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.4 0.4 2.0 1.6 2.4 1.9 0.0 0.2 0.4 0.1
Growth +12.7% +354.5% −18.8% +44.7% −20.5% −100.0% +77.8% −75.0%
Operating income −14.3 −14.2 −15.8 −14.0 −31.1 −29.7 −29.3 −16.6 −18.6 −35.1
Net income −14.5 −16.1 −17.6 −16.4 −23.2 −50.3 −65.0 −24.9 −18.4 −33.0
Growth
EPS, diluted n/a n/a n/a n/a −3.00 −5.78 −106.19 −6.50 −1.75 −0.32

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Operating margin−3,622.8%Net margin−3,688.3%Free cash flow margin−3,676.6%Fiscal year 2018Operating margin−3,204.3%Net margin−3,627.3%Free cash flow margin−3,246.4%Fiscal year 2019Operating margin−782.4%Net margin−871.8%Free cash flow margin−738.1%Fiscal year 2020Gross margin57.1%Operating margin−854.9%Net margin−1,003.6%Free cash flow margin−880.5%Fiscal year 2021Gross margin38.3%Operating margin−1,312.1%Net margin−978.8%Free cash flow margin−1,475.5%Fiscal year 2022Gross margin115.0%Operating margin−1,576.3%Net margin−2,670.0%Free cash flow margin−2,378.5%Fiscal year 2023Fiscal year 2024Operating margin−7,392.9%Net margin−11,069.8%Free cash flow margin−8,339.6%Fiscal year 2025Operating margin−4,650.5%Net margin−4,594.3%Free cash flow margin−3,830.0%Fiscal year 2026Operating margin−35,141.0%Net margin−33,044.0%Free cash flow margin−23,796.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin n/a n/a n/a 57.1% 38.3% 115.0% n/a n/a n/a n/a
Operating margin −3,622.8% −3,204.3% −782.4% −854.9% −1,312.1% −1,576.3% n/a −7,392.9% −4,650.5% −35,141.0%
Net margin −3,688.3% −3,627.3% −871.8% −1,003.6% −978.8% −2,670.0% n/a −11,069.8% −4,594.3% −33,044.0%
Free cash flow margin −3,676.6% −3,246.4% −738.1% −880.5% −1,475.5% −2,378.5% n/a −8,339.6% −3,830.0% −23,796.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−13.2Capital expenditure−1.3Free cash flow−14.5Fiscal year 2018Operating cash flow−13.5Capital expenditure−0.9Free cash flow−14.4Fiscal year 2019Operating cash flow−14.0Capital expenditure−0.9Free cash flow−14.9Fiscal year 2020Operating cash flow−13.3Capital expenditure−1.1Free cash flow−14.4Fiscal year 2021Operating cash flow−30.1Capital expenditure−4.9Free cash flow−35.0Fiscal year 2022Operating cash flow−37.5Capital expenditure−7.3Free cash flow−44.8Fiscal year 2023Operating cash flow−30.4Capital expenditure−5.7Free cash flow−36.2Fiscal year 2024Operating cash flow−18.6Capital expenditure−0.2Free cash flow−18.8Fiscal year 2025Operating cash flow−15.3Capital expenditure−0.0Free cash flow−15.3Fiscal year 2026Operating cash flow−23.2Capital expenditure−0.6Free cash flow−23.8
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −13.2 −13.5 −14.0 −13.3 −30.1 −37.5 −30.4 −18.6 −15.3 −23.2
Capital expenditure −1.3 −0.9 −0.9 −1.1 −4.9 −7.3 −5.7 −0.2 −0.0 −0.6
Free cash flow −14.5 −14.4 −14.9 −14.4 −35.0 −44.8 −36.2 −18.8 −15.3 −23.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash15.9Shareholders’ equity8.9Fiscal year 2018Cash4.4Shareholders’ equity16.2Fiscal year 2019Cash4.4Shareholders’ equity2.5Fiscal year 2020Cash55.1Shareholders’ equity56.6Fiscal year 2021Cash77.4Shareholders’ equity108.6Fiscal year 2022Cash22.7Shareholders’ equity63.5Fiscal year 2023Cash4.3Shareholders’ equity15.4Fiscal year 2024Cash14.2Shareholders’ equity21.3Fiscal year 2025Cash8.6Shareholders’ equity14.9Fiscal year 2026Cash56.4Shareholders’ equity85.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 15.9 4.4 4.4 55.1 77.4 22.7 4.3 14.2 8.6 56.4
Shareholders’ equity 8.9 16.2 2.5 56.6 108.6 63.5 15.4 21.3 14.9 85.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023† 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025 FY2026† 30 Jun 2026
Revenue and profit
0.4 0.4 2.0 1.6 2.4 1.9 0.0 0.2 0.4 0.1
Growth +12.7% +354.5% −18.8% +44.7% −20.5% −100.0% +77.8% −75.0%
n/a n/a n/a 0.7 1.5 0.2 n/a n/a n/a n/a
n/a n/a n/a 0.9 0.9 2.2 n/a n/a n/a n/a
Growth −2.8% +138.4%
4.1 4.0 5.5 3.6 10.0 9.8 10.3 5.2 8.3 19.6
10.6 10.7 12.3 11.4 22.0 21.8 19.0 11.7 10.7 10.6
−14.3 −14.2 −15.8 −14.0 −31.1 −29.7 −29.3 −16.6 −18.6 −35.1
Growth
n/a n/a n/a n/a n/a n/a n/a n/a −18.4 −33.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−14.5 −16.1 −17.6 −16.4 −23.2 −50.3 −65.0 −24.9 −18.4 −33.0
Growth
Per share
n/a n/a n/a n/a −3.00 −5.78 −106.19 −6.50 −1.75 −0.32
n/a n/a n/a n/a −3.00 −5.78 −106.19 −6.50 −1.75 −0.32
Growth
n/a n/a n/a n/a 7.8 8.7 0.6 3.8 10.5 104.1
n/a n/a n/a n/a 7.8 8.7 0.6 3.8 10.5 104.1
Growth +11.5% −93.0% +526.0% +174.1% +891.1%

† The diluted share count jumps at 2023 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 46.9% a year over five years.
  • Operating margin is down 33,828.9 points on five years ago, at -35,141.0%.
  • A net loss in 10 of 10 years on file.